Mum and dad investors can back pad with whatever nuggets they can find in the Qtrly but serious and large scale investors are only interested in solid FDA approval/partnership(s) news hence not getting sucked into running commentary (thrice bitten, shy forever) and this resulted in a flat share price and an average trading volume. If no solid news in the next 6-8 weeks then I am expecting SP to be hovering around 20c or less.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-41
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.41 |
Change
-0.055(3.75%) |
Mkt cap ! $1.581B | |||
| Open | High | Low | Value | Volume |
| $1.45 | $1.46 | $1.37 | $5.191M | 3.696M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 32066 | $1.41 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.42 | 46466 | 10 |
View Market Depth
| Last trade - 12.57pm 09/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |